Clinical Trial Update: A Clinical Trial to Assess the Efficacy and Safety of the Combination of a Drug Call Quizartinib With Chemotherapy (FLAG-IDA) in Patients With Acute Myeloid Leukemia That Has Not Responded to the First Treatment or That Has Returned After the First Treatment [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating the combination of quizartinib with FLAG-IDA chemotherapy in adults with acute myeloid leukemia that is refractory or relapsed after…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Quizartinib (Quizartinib)

Snippet

Sponsor: PETHEMA Foundation | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: UNKNOWN